Plavsic Mark — SEC Form 4 filings

SEC reporting owner CIK 1868719. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-10-16 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aura Biosciences, Inc. (AURA)Chief Technology Officer64 legs · 37,593 sh · $246,9104

Form 4 filings — Plavsic Mark

FiledFormIssuerReported transactionsSource
2026-03-034Aura Biosciences, Inc. (AURA)Grant/award (A): 62,339 @ $0 · Grant/award (A): 112,661 (derivative) @ $0EDGAR
2026-02-174Aura Biosciences, Inc. (AURA)Sale (S): 15,890 @ $5.05EDGAR
2025-10-164Aura Biosciences, Inc. (AURA)Sale (S): 12,169 @ $6.35EDGAR
2025-02-184Aura Biosciences, Inc. (AURA)Sale (S): 2,151 @ $7.75EDGAR
2025-02-044Aura Biosciences, Inc. (AURA)Grant/award (A): 90,475 @ $0 · Grant/award (A): 59,525 (derivative) @ $0EDGAR
2024-10-164Aura Biosciences, Inc. (AURA)Sale (S): 7,383 @ $9.85EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1868719 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →